siRNA treatment reduces triglycerides in patients along with rare disorder

.ANALYSIS EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels through 80% as well as reduced the threat of pancreatitis in clients with chronic chylomicronemia, with or even without a hereditary medical diagnosis.